unilife corp
(UNIS:Consolidated Issue listed on NASDAQ Global Market)

Executive Profile*

Background*

Dr. Ramin Mojdehbakhsh, Ph.D. has been the Chief Operating Officer and Executive Vice President of Unilife Corporation since February 7, 2011. Dr. Mojdehbakhsh served as a Vice President and General Manager of Becton Dickinson (BD) Pharmaceutical Systems, North America. Dr. Mojdeh has more than 25 years of business leadership experience across multiple industries, including 18 years in the design, development, manufacturing, sales and marketing of therapeutic and diagnostic ... medical devices for several multinational companies, including BD, GE Healthcare and Boston Scientific (formerly "Guidant Corporation"). He has developed and maintained strong relationships with many pharmaceutical manufacturers that utilize prefilled syringes for their injectable drugs and vaccines. Dr. Mojdehbakhsh spent the last eight years working with BD, one of the world's leading suppliers of medical devices, including prefilled syringes. He served as the Vice President and General Manager of BD Medical, Pharmaceutical Systems, North America from 2008 to 2010. In this role, he directed all aspects of the North America operations including sales, marketing, business development, commercial development, finance, R&D, manufacturing, operations, quality assurance, regulatory affairs, legal affairs and human resources. During this time, Dr. Mojdeh served as a key board member of the Business Strategy Council that led the worldwide business growth strategy for BD Pharmaceutical Systems, whose annual revenues exceeded $1 billion. He also led the creation of an innovative new growth business for BD Pharmaceutical Systems in advanced drug delivery. From 2002 to 2008, Dr. Mojdeh held the position of the Worldwide Vice President of Research and Development for BD Medical, responsible for technology and product innovation and commercialization for the business areas of medical surgical systems, diabetes care, pharmaceutical systems and ophthalmic systems with combined annual revenues of over $4 billion. During this time, he led the process of revamping the product development functions for BD Medical. He was also a board member of BD Ventures Inc., the venture capital arm of BD, which oversaw all technology and innovation activities across BD. Furthermore, he has served as the Chairman of the Advanced Drug Delivery Council, aimed at identifying and developing new growth strategies in the drug delivery device space. Prior to his work with BD, Dr. Mojdehbakhsh served as Business Director of Invasive Cardiology at GE Healthcare since 2002, and spent ten years with Guidant Corporation, where he held several management positions including Business Director, Advanced Patient Management from 1999 to 2002 and Business Director, Advanced Patient Monitoring System from 1996 to 1999. Dr. Mojdehbakhsh holds a Ph.D. in Computer Science from the University of Minnesota, Minneapolis Minnesota, and his MBA from Kellogg Graduate School of Management, Northwestern University, Evanston, Illinois.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
UNIS:US	$3.02 USD	-0.145

COMPETITOR COMPENSATION